|
1 -> 148
|
MRLDRLTNKFQLALADAQSLALGHDNQFIEPLHLMSALLNQEGGSVSPLLTSAGINAGQLRTDINQALNRLPQVEGTGGDVQPSQDLVRVLNLCDKLAQKRGDNFISSELFVLAALESRGTLADILKAAGATTANITQAIEQMRGGES
|
UniProt: In isoform ClpB-3..
|
|
3 -> 146
|
LDRLTNKFQLALADAQSLALGHDNQFIEPLHLMSALLNQEGGSVSPLLTSAGINAGQLRTDINQALNRLPQVEGTGGDVQPSQDLVRVLNLCDKLAQKRGDNFISSELFVLAALESRGTLADILKAAGATTANITQAIEQMRGG
|
UniProt: Clp R.
|
|
6 -> 71
|
LTNKFQLALADAQSLALGHDNQFIEPLHLMSALLNQEGGSVSPLLTSAGINAGQLRTDINQALNRL
|
UniProt: Repeat 1; Sequence Annotation Type: region of interest.
|
|
7 -> 7
|
T
|
UniProt: Loss of chaperone activity..
|
|
17 -> 68
|
AQSLALGHDNQFIEPLHLMSALLNQEGGSVSPLLTSAGINAGQLRTDINQAL
|
|
|
83 -> 146
|
PSQDLVRVLNLCDKLAQKRGDNFISSELFVLAALESRGTLADILKAAGATTANITQAIEQMRGG
|
UniProt: Repeat 2; Sequence Annotation Type: region of interest.
|
|
84 -> 84
|
S
|
UniProt: No effect..
|
|
93 -> 93
|
L
|
UniProt: Loss of chaperone activity. Retains ATPase activity..
|
|
94 -> 145
|
CDKLAQKRGDNFISSELFVLAALESRGTLADILKAAGATTANITQAIEQMRG
|
|
|
96 -> 97
|
KL
|
UniProt: In Ref. 1; AAA24422..
|
|
97 -> 97
|
L
|
UniProt: 75% decrease in chaperone activity; retains ATPase activity..
|
|
103 -> 103
|
D
|
UniProt: Loss of chaperone activity..
|
|
109 -> 109
|
E
|
UniProt: Loss of chaperone activity..
|
|
110 -> 110
|
L
|
UniProt: 30% decrease in chaperone activity; retains ATPase activity..
|
|
122 -> 122
|
L
|
UniProt: In Ref. 1; AAA24422..
|
|
149 -> 149
|
V
|
UniProt: In isoform ClpB-3..
|
|
159 -> 340
|
QALKKYTIDLTERAEQGKLDPVIGRDEEIRRTIQVLQRRTKNNPVLIGEPGVGKTAIVEGLAQRIINGEVPEGLKGRRVLALDMGALVAGAKYRGEFEERLKGVLNDLAKQEGNVILFIDELHTMVGAGKADGAMDAGNMLKPALARGELHCVGATTLDEYRQYIEKDAALERRFQKVFVAE
|
UniProt: NBD1; Sequence Annotation Type: region of interest.
|
|
203 -> 337
|
VLIGEPGVGKTAIVEGLAQRIINGEVPEGLKGRRVLALDMGALVAGAKYRGEFEERLKGVLNDLAKQEGNVILFIDELHTMVGAGKADGAMDAGNMLKPALARGELHCVGATTLDEYRQYIEKDAALERRFQKVF
|
|
|
206 -> 213
|
GEPGVGKT
|
UniProt: ATP 1.
|
|
212 -> 212
|
K
|
UniProt: Loss of ability to form oligomers even in the presence of ATP. Loss of chaperone activity..
|
|
248 -> 257
|
GAKYRGEFEE
|
potential substrate binding site located at the central pore of the first AAA domain
|
|
251 -> 251
|
Y
|
UniProt: Decrease in ability to disaggregate proteins due to decreased substrate-binding activity. Retains hexameric quaternary structure and ATPase activity..
|
|
254 -> 254
|
E
|
UniProt: Decrease in ability to disaggregate proteins due to decreased substrate-binding activity. Retains hexameric quaternary structure and ATPase activity; when associated with A-257..
|
|
257 -> 257
|
E
|
UniProt: Decrease in ability to disaggregate proteins due to decreased substrate-binding activity. Retains hexameric quaternary structure and ATPase activity; when associated with A-254..
|
|
276 -> 279
|
FIDE
|
|
|
279 -> 279
|
E
|
UniProt: No effect on oligomerization..
|
|
332 -> 332
|
R
|
UniProt: Loss of ability to form oligomers..
|
|
341 -> 545
|
PSVEDTIAILRGLKERYELHHHVQITDPAIVAAATLSHRYIADRQLPDKAIDLIDEAASSIRMQIDSKPEELDRLDRRIIQLKLEQQALMKESDEASKKRLDMLNEELSDKERQYSELEEEWKAEKASLSGTQTIKAELEQAKIAIEQARRVGDLARMSELQYGKIPELEKQLEAATQLEGKTMRLLRNKVTDAEIAEVLARWTG
|
UniProt: Linker; Sequence Annotation Type: region of interest.
|
|
342 -> 443
|
SVEDTIAILRGLKERYELHHHVQITDPAIVAAATLSHRYIADRQLPDKAIDLIDEAASSIRMQIDSKPEELDRLDRRIIQLKLEQQALMKESDEASKKRLDM
|
|
|
409 -> 525
|
PEELDRLDRRIIQLKLEQQALMKESDEASKKRLDMLNEELSDKERQYSELEEEWKAEKASLSGTQTIKAELEQAKIAIEQARRVGDLARMSELQYGKIPELEKQLEAATQLEGKTMR
|
Middle domain
|
|
410 -> 455
|
EELDRLDRRIIQLKLEQQALMKESDEASKKRLDMLNEELSDKERQY
|
|
|
425 -> 425
|
E
|
alternate sequence E → A: increase in DnaK dependent disaggregation activity (gain of function mutation)
|
|
432 -> 432
|
E
|
alternate sequence E → A: loss of DnaK dependent disaggregation activity (loss of function mutation); normal oligomerization; no effect on substrate induced ATPase activity; mutant trapped in repressed state
|
|
456 -> 520
|
SELEEEWKAEKASLSGTQTIKAELEQAKIAIEQARRVGDLARMSELQYGKIPELEKQLEAATQLE
|
|
|
476 -> 476
|
K
|
alternate sequence K → C: increase in DnaK dependent disaggregation activity (gain of function mutation); increase in substrate (casein) induced ATPase activity; mutant trapped in derepressed state
|
|
480 -> 480
|
E
|
alternate sequence E → C: loss of DnaK dependent disaggregation activity (loss of function mutation), normal oligomerization; no effect on substrate induced ATPase activity; mutant trapped in repressed state
|
|
495 -> 503
|
LARMSELQY
|
helix 3 of the M domain interacts with the first ATPase domain (AAA1)
|
|
499 -> 499
|
S
|
alternate sequence S → D: defective in disaggregation activity; translocation competent (ie. retains 'threading' activity); increased basal ATPase rate and hyperstimulation of substrate (casein) induced ATPase activity
|
|
503 -> 503
|
Y
|
alternate sequence Y → D: defective in disaggregation activity; translocation competent (ie. retains 'threading' activity); increased basal ATPase rate and hyperstimulation of substrate (casein) induced ATPase activity
|
|
530 -> 758
|
KVTDAEIAEVLARWTGIPVSRMMESEREKLLRMEQELHHRVIGQNEAVDAVSNAIRRSRAGLADPNRPIGSFLFLGPTGVGKTELCKALANFMFDSDEAMVRIDMSEFMEKHSVSRLVGAPPGYVGYEEGGYLTEAVRRRPYSVILLDEVEKAHPDVFNILLQVLDDGRLTDGQGRTVDFRNTVVIMTSNLGSDLIQERFGELDYAHMKELVLGVVSHNFRPEFINRID
|
|
|
543 -> 543
|
W
|
UniProt: No effect on chaperone activity or ability to form oligomers..
|
|
555 -> 765
|
EREKLLRMEQELHHRVIGQNEAVDAVSNAIRRSRAGLADPNRPIGSFLFLGPTGVGKTELCKALANFMFDSDEAMVRIDMSEFMEKHSVSRLVGAPPGYVGYEEGGYLTEAVRRRPYSVILLDEVEKAHPDVFNILLQVLDDGRLTDGQGRTVDFRNTVVIMTSNLGSDLIQERFGELDYAHMKELVLGVVSHNFRPEFINRIDEVVVFHP
|
UniProt: NBD2; Sequence Annotation Type: region of interest.
|
|
596 -> 760
|
RPIGSFLFLGPTGVGKTELCKALANFMFDSDEAMVRIDMSEFMEKHSVSRLVGAPPGYVGYEEGGYLTEAVRRRPYSVILLDEVEKAHPDVFNILLQVLDDGRLTDGQGRTVDFRNTVVIMTSNLGSDLIQERFGELDYAHMKELVLGVVSHNFRPEFINRIDEV
|
|
|
605 -> 612
|
GPTGVGKT
|
UniProt: ATP 2. Walker A motif within NBD-2
|
|
611 -> 611
|
K
|
UniProt: No effect on ability to form oligomers. Loss of chaperone activity..
|
|
653 -> 653
|
Y
|
alternate seqence Y → A: mutation results in loss of substrate translocation through the central pore of the ClpB oligomer in vitro
|
|
675 -> 678
|
LLDE
|
|
|
678 -> 678
|
E
|
UniProt: No effect on oligomerization..
|
|
756 -> 756
|
R
|
UniProt: No effect on oligomerization. Loss of ATPase activity..
|
|
766 -> 857
|
LGEQHIASIAQIQLKRLYKRLEERGYEIHISDEALKLLSENGYDPVYGARPLKRAIQQQIENPLAQQILSGELVPGKVIRLEVNEDRIVAVQ
|
UniProt: C-terminal; Sequence Annotation Type: region of interest.
|
|
770 -> 857
|
HIASIAQIQLKRLYKRLEERGYEIHISDEALKLLSENGYDPVYGARPLKRAIQQQIENPLAQQILSGELVPGKVIRLEVNEDRIVAVQ
|
|
|
797 -> 797
|
D
|
UniProt: No effect..
|
|
813 -> 815
|
GAR
|
UniProt: No effect on oligomerization..
|
|
815 -> 815
|
R
|
UniProt: Loss of ability to form oligomers; loss of chaperone activity..
|
|
819 -> 819
|
R
|
UniProt: Loss of ability to form oligomers; loss of chaperone activity..
|
|
826 -> 826
|
E
|
UniProt: No effect..
|
|
55 -> 189
|
INAGQLRTDINQALNRLPQVEGTGGDVQPSQDLVRVLNLCDKLAQKRGDNFISSELFVLAALESRGTLADILKAAGATTANITQAIEQMRGGESVNDQGAEDQRQALKKYTIDLTERAEQGKLDPVIGRDEEIRR
|
|
|
194 -> 295
|
LQRRTKNNPVLIGEPGVGKTAIVEGLAQRIINGEVPEGLKGRRVLALDMGALVAGAKYRGEFEERLKGVLNDLAKQEGNVILFIDELHTMVGAGKADGAMDA
|
|
|
448 -> 612
|
LSDKERQYSELEEEWKAEKASLSGTQTIKAELEQAKIAIEQARRVGDLARMSELQYGKIPELEKQLEAATQLEGKTMRLLRNKVTDAEIAEVLARWTGIPVSRMMESEREKLLRMEQELHHRVIGQNEAVDAVSNAIRRSRAGLADPNRPIGSFLFLGPTGVGKT
|
|
|
618 -> 697
|
LANFMFDSDEAMVRIDMSEFMEKHSVSRLVGAPPGYVGYEEGGYLTEAVRRRPYSVILLDEVEKAHPDVFNILLQVLDDG
|
|